Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

RORA may help regulate hair growth by affecting hair follicle stem cells.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

DKK4 can be used to improve wool quality in Zhexi Angora rabbits.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

PRX102 is essential for rice root hair growth by helping transport substances to the tips.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

We need better ways to test and understand SARMs to make safer and more effective treatments.